Publications by authors named "Barbara Akla"

Claim this Profile
E
Efficacy of the Antibody-Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors.
Barbara Akla, Matthieu Broussas, Noureddine Loukili, Alain Robert, Charlotte Beau-Larvor

Mol Cancer Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells.
Matthieu Broussas, Nicolas Boute, Barbara Akla, Sven Berger, Charlotte Beau-Larvor

Mol Cancer Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional responses and in vivo anti-tumour activity of h7C10: a humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors.
Giuseppe Pandini, Thierry Wurch, Barbara Akla, Nathalie Corvaia, Antonino Belfiore

Eur J Cancer· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging.
Jacques Monteil, Aurélie Dutour, Barbara Akla, Thierry Chianéa, Valérie Le Brun

Mol Imaging Biol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new orthotopic model of human breast cancer in immunocompetent rats.
Barbara Akla, Jacques Monteil, François Paraf, Franck Sturtz, Michel Rigaud

Anticancer Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis